Regulus Therapeutics Inc (RGLS) is near the top in its industry group according to InvestorsObserver. RGLS gets an overall rating of 57. That means it scores higher than 57 percent of stocks. Regulus Therapeutics Inc gets a 73 rank in the Biotechnology industry. Biotechnology is number 55 out of 148 industries.
RGLS has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on RGLS!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 57 means the stock is more attractive than 57 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Regulus Therapeutics Inc Stock Today?
Regulus Therapeutics Inc (RGLS) stock is trading at $1.30 as of 9:30 AM on Thursday, Nov 2, a gain of $0.07, or 5.68% from the previous closing price of $1.23. The stock has traded between $1.25 and $1.30 so far today. Volume today is low. So far 9,785 shares have traded compared to average volume of 18,752 shares.
Click Here to get the full Stock Report for Regulus Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
